Efferon International

Next-generation hemoadsorption devices to treat sepsis and septic shock. Company's flagship product, Efferon LPS single-use hemoadsorption device is granted CE mark approval under EU MDR. 

Clinically validated approach, over 25.000 treated critical patients.

Founded in 2016 to translate the most advanced polymeric adsorbent technology into routine clinical practice and to fight morbid diseases.